Latest Insider Transactions at Veracyte, Inc. (VCYT)
This section provides a real-time view of insider transactions for Veracyte, Inc. (VCYT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VERACYTE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VERACYTE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2020
|
John Walter Hanna Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+18.19%
|
$425,000
$20.21 P/Share
|
|
Nov 05
2020
|
John Walter Hanna Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,406
-2.7%
|
$262,646
$41.21 P/Share
|
|
Nov 05
2020
|
John Walter Hanna Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,406
+3.89%
|
$44,842
$7.52 P/Share
|
|
Oct 20
2020
|
Mark Ho |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+18.54%
|
$45,000
$6.45 P/Share
|
|
Oct 19
2020
|
Fred E Cohen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$70,000
$7.6 P/Share
|
|
Oct 08
2020
|
Bonnie H Anderson Director |
SELL
Open market or private sale
|
Direct |
50,000
-18.5%
|
$1,900,000
$38.0 P/Share
|
|
Oct 08
2020
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+15.61%
|
$400,000
$8.86 P/Share
|
|
Oct 06
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
2,500
-3.05%
|
$87,500
$35.21 P/Share
|
|
Oct 06
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.96%
|
$50,000
$20.21 P/Share
|